6,678 trials
Hypogonadism · Benign Prostatic Hyperplasia
Primary: Effects of Testosterone Gel Alone or in Combination With Oral Dutasteride on Prostate Volume in Hypogonadal Men With Benign Prostatic Hyperplasia. — 54.2; 44.4; 58.3…
Non-small Cell Lung Cancer (NSCLC)
Primary: Progression Free Survival (PFS) — 4.8; 2.6 month
Acute Back Strain
Primary: Mean Change From Baseline to End of Treatment (EOT) in Response to Modified Brief Pain Inventory (mBPI) Question 5: Average Pain Over the Last 24 Hours — 6.46; -3.95…
Glaucoma
Primary: Mean Change From Baseline in Intraocular Pressure, 8 AM, at 3 Months — -3.13; -2.57 mmHg
Overactive Bladder
Primary: Cerebral Spinal Fluid Levels of Sanctura XR® at Day 10 Post-dose — NA Nanograms (ng) per milliliter (mL)
Diabetes Mellitus, Type 2
Primary: HbA1c: Change From Baseline to Study Endpoint — -1.72; -1.13 percent — p=<0.0001
Overactive Bladder
Primary: Mean Number of Micturition-related Nocturnal Urgency Episodes Per 24 Hours — 2.93; 2.91 episodes per 24 hours
Posttraumatic Stress Disorder
Primary: Clinician Administered PTSD Scale (CAPS) — 72.6; 65.4; 40.7; 49.0 units on a scale — p=.01
Severe Renal Impairment
Primary: Area Under the Curve From 0 to Tau (AUC 0-t (ng*h/mL)) — 175; 145 nanogram hour per milliliter (ng•h/mL)
Healthy Volunteers
Primary: Area Under the Curve From Time 0 to Tau (AUC 0-τ) — 113.92 ng•h/mL
Difficult Airway · Anesthesia; Functional
Primary: Airway Seal Pressure — 30; 30 cmH2O
Type 2 Diabetes Mellitus
Primary: Flow Mediated Dilation — 6.8; 5.5 percent change
Skin Diseases, Bacterial
Primary: Number of Clinically Evaluable (CE) Patients With Clinical Response of Cure at the Test-of-cure (TOC) Visit — 162; 152 participants
Skin/Soft Tissue Infections · Methicillin Resistant Staphylococcus Aureus (MRSA)
Primary: Clinical Outcome in Participants With Baseline Methicillin-Resistant Staphylococcus Aureus (MRSA) at End of Study (EOS) for Per-Protocol (PP) Population — 84.1; 79.9…
Dwarfism, Pituitary
Primary: Change From Baseline in Serum Insulin Like Growth Factor-1 Standard Deviation Score (IGF-1 SDS) Levels at Week 4 — -2.04; -2.22; 1.38; 0.85 nanogram/millilter (ng/mL)…